As global markets navigate the complexities of rising oil prices and geopolitical tensions, Asia's small-cap sector presents unique opportunities for investors seeking growth beyond the mainstream indices. In this environment, identifying stocks with strong fundamentals and resilience to external pressures can be key to uncovering potential gems in the region.
| Name | Debt To Equity | Revenue Growth | Earnings Growth | Health Rating |
|---|---|---|---|---|
| CNMC Goldmine Holdings | 0.84% | 32.52% | 78.36% | ★★★★★★ |
| Cybozu | 0.18% | 16.90% | 52.26% | ★★★★★★ |
| DeHua TB New Decoration MaterialLtd | 0.63% | 1.50% | 2.14% | ★★★★★★ |
| Henan Zhongfu IndustrialLtd | 24.92% | 12.75% | 38.17% | ★★★★★★ |
| FINDEX | NA | 8.26% | 22.39% | ★★★★★★ |
| Magnate Technology | 77.36% | 10.92% | 35.95% | ★★★★★☆ |
| Zhejiang Jolly PharmaceuticalLTD | 21.31% | 17.83% | 29.70% | ★★★★★☆ |
| Henan Lingrui Pharmaceutical | 7.45% | 9.15% | 18.27% | ★★★★★☆ |
| Sing Investments & Finance | 0.15% | 7.06% | 8.65% | ★★★★☆☆ |
| Shengda ResourcesLtd | 54.08% | 7.99% | 3.75% | ★★★☆☆☆ |
Below we spotlight a couple of our favorites from our exclusive screener.
Simply Wall St Value Rating: ★★★★★☆
Overview: Bank of Ayudhya Public Company Limited, along with its subsidiaries, offers a range of commercial banking products and services to individuals, corporates, small and medium-sized businesses, and financial institutions with a market capitalization of THB305.26 billion.
Operations: Bank of Ayudhya generates revenue primarily from its commercial banking services, targeting a diverse clientele including individuals, corporates, and small to medium enterprises. The bank's financial performance is reflected in its market capitalization of THB305.26 billion.
Bank of Ayudhya, a smaller player in the Asian banking sector, showcases robust financial health with total assets of THB2,594.5 billion and equity at THB449.9 billion. Its reliance on customer deposits for 79% of liabilities suggests a stable funding base. Despite a volatile share price recently, its earnings growth outpaced the industry at 10.2%, and it trades 31.1% below estimated fair value, indicating potential undervaluation. The bank has sufficient allowance for bad loans at 121%, though non-performing loans are high at 4%. Recent earnings reveal steady performance with net income reaching THB16.91 billion for six months ending June 2026.
Gain insights into Bank of Ayudhya's past trends and performance with our Past report.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Zanyu Technology Group Co., Ltd. operates in the research, development, manufacture, and sale of surfactants, oleo chemicals, and personal care products both in China and internationally with a market cap of CN¥4.42 billion.
Operations: The company generates revenue primarily through the sale of surfactants, oleo chemicals, and personal care products. It has a net profit margin of 5.2%, indicating its profitability after accounting for all expenses.
Zanyu Technology Group stands out with its robust 20.3% earnings growth over the past year, significantly surpassing the Chemicals industry's 3.8%. Its earnings are projected to rise by 43.16% annually, indicating strong future potential. Despite a high net debt to equity ratio of 55.6%, interest payments are well covered at a solid 5.5x EBIT coverage, suggesting manageable debt levels. Trading at an attractive valuation, Zanyu is priced at 77.1% below its estimated fair value and offers good relative value compared to peers and industry standards, making it an intriguing prospect for investors seeking growth opportunities in Asia's market landscape.
Explore historical data to track Zanyu Technology Group's performance over time in our Past section.
Simply Wall St Value Rating: ★★★★☆☆
Overview: Guizhou Chanhen Chemical Corporation is involved in the mining and beneficiation of phosphate and the processing of phosphorus in China, with a market cap of CN¥21.30 billion.
Operations: The company generates revenue primarily from the mining and beneficiation of phosphate and processing of phosphorus. It faces costs associated with these operations, impacting its profitability. The net profit margin shows distinct trends over recent periods, reflecting changes in cost management and pricing strategies.
Guizhou Chanhen Chemical, a promising player in the Asian market, has shown impressive earnings growth of 21.8% over the past year, outpacing the Chemicals industry average of 3.8%. The company is trading at a significant discount, valued at 66% below its estimated fair value. Despite its free cash flow not being positive recently, Guizhou Chanhen's interest payments are comfortably covered by EBIT with an impressive coverage ratio of 313 times. Additionally, it maintains a satisfactory net debt to equity ratio of 12.7%, reflecting prudent financial management amidst recent strategic moves like stock repurchases and dividend increases.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com